New Results
Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2
Taylor P. Enrico, Wayne Stallaert, Elizaveta T. Wick, Peter Ngoi, Seth M. Rubin, Nicholas G. Brown, Jeremy E. Purvis, Michael J. Emanuele
doi: https://doi.org/10.1101/2021.04.23.441013
Taylor P. Enrico
1Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, North Carolina, USA.
2Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, North Carolina, USA.
Wayne Stallaert
3Department of Genetics. The University of North Carolina at Chapel Hill. Chapel Hill, North Carolina, USA.
Elizaveta T. Wick
1Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, North Carolina, USA.
2Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, North Carolina, USA.
Peter Ngoi
4Department of Chemistry and Biochemistry. University of California at Santa Cruz, Santa Cruz, CA, USA
Seth M. Rubin
4Department of Chemistry and Biochemistry. University of California at Santa Cruz, Santa Cruz, CA, USA
Nicholas G. Brown
1Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, North Carolina, USA.
2Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, North Carolina, USA.
Jeremy E. Purvis
2Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, North Carolina, USA.
3Department of Genetics. The University of North Carolina at Chapel Hill. Chapel Hill, North Carolina, USA.
Michael J. Emanuele
1Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, North Carolina, USA.
2Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, North Carolina, USA.
Article usage
Posted April 24, 2021.
Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2
Taylor P. Enrico, Wayne Stallaert, Elizaveta T. Wick, Peter Ngoi, Seth M. Rubin, Nicholas G. Brown, Jeremy E. Purvis, Michael J. Emanuele
bioRxiv 2021.04.23.441013; doi: https://doi.org/10.1101/2021.04.23.441013
Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2
Taylor P. Enrico, Wayne Stallaert, Elizaveta T. Wick, Peter Ngoi, Seth M. Rubin, Nicholas G. Brown, Jeremy E. Purvis, Michael J. Emanuele
bioRxiv 2021.04.23.441013; doi: https://doi.org/10.1101/2021.04.23.441013
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8749)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12086)
- Cell Biology (17403)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16795)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11582)
- Neuroscience (60936)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10423)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)